Skip to main navigationSkip to main content
The University of Southampton
Biological Sciences

Research project: Identifying peptide candidates for a vaccine against the contagious cancer, Devil Facial Tumour Disease

Currently Active: 

Developing a peptide vaccine that will target the contagious cancer, currently threatening the Tasmanian Devil with extinction.

Devil Facial Tumour Disease (DFTD) is an infectious cancer that is eradicating the Tasmanian devil, the world’s largest remaining marsupial carnivore. DFTD arose originally from a neural (Schwann) cell and the devil’s immune system does not respond to it. We will identify protein changes between DFTD and normal devil Schwann cells to identify proteins that can trigger immune responses to DFTD. These are potential targets for a DFTD vaccine that will save the devil from extinction. The research will also enhance our understanding of how cancers avoid the immune system, which could have implications for cancer treatment in humans.

Funding: Leverhulme Trust Project Grant

Funding dates: 2015-2018


Devil facial tumour
Devil facial tumour
Tasmanian Devil
Tasmanian Devil

Related research groups

Molecular and Cellular Biosciences
Cancer Sciences Research group
Share this research project Share this on Facebook Share this on Twitter Share this on Weibo

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.